All NewsPractice Management
All VideosExpert InterviewsPodcastsMedical World NewsViewpointsInsightsCase Based Roundtable SeriesCase StudiesCase of the QuarterPractice OwnershipRapid ReadoutWhat’s Your WhEYE?
Conference CoverageConference ListingConference Recaps
Blog
Digital EditionSupplements And Featured PublicationsiTech
Partners
Job BoardSponsored
SubscribeCE
AMD
Allergy
Blepharitis
COVID-19
Cataract
Comanagement
Comprehensive Eye Exams
Conjunctivitis
Contact Lenses
Cornea
DME
Diabetic Eye Disease
Dry Eye
Geographic Atrophy
Glasses
Glaucoma
LASIK
Lens Technology
Lid and Lash
Myopia
Nutrition
OCT
Ocular Surface Disease
Optic Relief
Patient Care
Pediatrics
Presbyopia
Ptosis
Refractive Surgery
Retina
Technology
Therapeutic Cataract & Refractive
Spotlight -
  • Geographic Atrophy
  • Myopia
EyeCare Network
  • Ophthalmology Times

  • Modern Retina

  • Optometry Times

  • Ophthalmology Times Europe

AMD
Allergy
Blepharitis
COVID-19
Cataract
Comanagement
Comprehensive Eye Exams
Conjunctivitis
Contact Lenses
Cornea
DME
Diabetic Eye Disease
Dry Eye
Geographic Atrophy
Glasses
Glaucoma
LASIK
Lens Technology
Lid and Lash
Myopia
Nutrition
OCT
Ocular Surface Disease
Optic Relief
Patient Care
Pediatrics
Presbyopia
Ptosis
Refractive Surgery
Retina
Technology
Therapeutic Cataract & Refractive
EyeCare Network
  • Ophthalmology Times

  • Modern Retina

  • Optometry Times

  • Ophthalmology Times Europe

    • Blog
    • Partners
    • Subscribe
    • CE
Advertisement

Big pharma helps homeless patient

April 17, 2018
By Benjamin P. Casella, OD, FAAO
Publication
Article
Optometry Times JournalVol. 10 No. 05
Volume 10
Issue 5

Chief Optometric Editor Ben Casella refuses to turn patients away if they cannot pay. He reminds himself-and all ODs-that the burden of care can be shared instead of carried alone.

Part of practicing in a somewhat urban environment is the street traffic outside of one’s front door. You just never know who will walk in (or with what malady or concern). Occasionally, someone from the bank building next door will come in with a missing screw to a frame temple. Our office policy is to always do the neighborly thing and fix a frame if we can, even if the owner of said frame isn’t a patient of ours.

With that said, another policy of ours is not to turn anyone away because of the inability to pay for care. This policy brings along with it the occasional homeless person who wanders in looking for help. Unfortunately, we are all aware that the prevalence of disease increases as socioeconomic status decreases. That’s just a fact of life.

Previously from Dr. Casella: Stop, Say hello, and shake my hand

Patient in need

So, when a homeless man came in year or so ago with profound glaucoma, I treated him as best I could with samples of prostaglandin analogs whenever I saw him (which was relatively frequently). During a casual conversation with a pharmaceutical rep, I was reminded of the fact that pharmaceutical companies offer programs in which patients can attain medications they need even if they can’t pay. I was able to easily get this patient signed up for the program.

He has since moved, and I hope he gets the health care he needs and deserves wherever he is. With no forwarding address, continuity of care is about as difficult as it can be in this case. However, the day I last saw him, he brought me an antique wooden chair to thank me for taking care of him. I have no idea where the chair came from, but I really appreciate having it in the office.

It takes a village

My thought process needs to be broken every now and then from the mantra that all corporations want to make nothing more than money. Most large pharmaceutical companies have patient assistant programs in place, and I need to do a better job of keeping this in mind the next time I see someone in need of care who cannot attain it. Those who treat homeless patients or patients with very limited resources don’t necessarily have to bear the burden of care all by themselves.

Read more from Dr. Casella here

Articles in this issue

How staff can help differentiate your practice
How staff can help differentiate your practice
Setting goals for success
Technology helps to diagnose corneal ectasia
Technology helps to diagnose corneal ectasia
How a study group can help you
Treating inflammation tackles filamentary keratitis
Treating inflammation tackles filamentary keratitis
Jeffrey J. Walline, OD, PhD-Associate dean for research, The Ohio State University College of Optometry
Big pharma helps homeless patient
6 healthy habits that don’t cost a fortune
6 healthy habits that don’t cost a fortune
Alzheimer’s disease and dementia impacted by diabetes
Diet change may affect glaucoma risk
Diet change may affect glaucoma risk

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
Co-op funds: What they are and how to use them
Co-op funds: What they are and how to use them
Dr. Brown: What I wish I knew before entering optometry
Dr. Brown: What I wish I knew before entering optometry
Carole Burns, OD, FCOVD
How to position patient lens transitions in your practice
Scott Schachter, OD
How to start incorporating dry eye in your practice
OD text groups keep the conversation going
OD text groups keep the conversation going
OD text groups keep the conversation going
OD text groups keep the conversation going
Video: Why contact lens wearers should use hydrogen peroxide
Video: Why contact lens wearers should use hydrogen peroxide
Understanding intense pulsed light
The impact of exercise on glaucoma
The impact of exercise on glaucoma
How alcohol impacts intraocular pressure, glaucoma
How alcohol impacts intraocular pressure, glaucoma
Related Content
Advertisement
Image Credit: © Dragana Gordic - stock.adobe.com

New and emerging myopia management: The impact of sleep

Ashley Wallace-Tucker, OD, FAAO, FSLS, Dipl ABO
May 3rd 2023
Article
Image Credit: © elnariz - stock.adobe.com

Behind the creation of the 20-20-20 rule for digital eye strain

Jeffrey Anshel, OD, FAAO
April 25th 2023
Article
Why you should travel the extra mile for your patients

Why you should travel the extra mile for your patients

Mike Brown, OD, MHS-CL, FAAO
August 29th 2022
Article
When pharmacies threaten treatment plans, look elsewhere

When pharmacies threaten treatment plans, look elsewhere

Benjamin P. Casella, OD, FAAO
May 3rd 2022
Article
The double standard of clinical care: Do as I say, not as I do

The double standard of clinical care: Do as I say, not as I do

Michael Brown, OD, MHS-CL, FAAO
April 19th 2022
Article
Keeping calm with positive vibes

Keeping calm with positive vibes

Benjamin P. Casella, OD, FAAO
March 28th 2022
Article
Related Content
Blog
Advertisement
Image Credit: © Dragana Gordic - stock.adobe.com

New and emerging myopia management: The impact of sleep

Ashley Wallace-Tucker, OD, FAAO, FSLS, Dipl ABO
May 3rd 2023
Article
Image Credit: © elnariz - stock.adobe.com

Behind the creation of the 20-20-20 rule for digital eye strain

Jeffrey Anshel, OD, FAAO
April 25th 2023
Article
Why you should travel the extra mile for your patients

Why you should travel the extra mile for your patients

Mike Brown, OD, MHS-CL, FAAO
August 29th 2022
Article
When pharmacies threaten treatment plans, look elsewhere

When pharmacies threaten treatment plans, look elsewhere

Benjamin P. Casella, OD, FAAO
May 3rd 2022
Article
The double standard of clinical care: Do as I say, not as I do

The double standard of clinical care: Do as I say, not as I do

Michael Brown, OD, MHS-CL, FAAO
April 19th 2022
Article
Keeping calm with positive vibes

Keeping calm with positive vibes

Benjamin P. Casella, OD, FAAO
March 28th 2022
Article
Advertisement
Recent Content
Swept source anterior segment OCT aids in early diagnosis of childhood glaucoma. - Image credit: ©Serhii—stock.adobe.com

Swept-source anterior segment-OCT aids in early diagnosis of childhood glaucoma

Four hands putting together puzzle pieces Image credit: AdobeStock/Johnstocker

Pangaea Data and Topcon Healthcare announce strategic investment

Closeup of dry eye before and after treatment. Image credit: AdobeStock/AlessandroGrandini

Iolyx Therapeutics releases phase 2 results for ILYX-002 in autoimmune-associated dry eye disease

FDA approves Alcon’s Tryptyr (AR-15512) for signs and symptoms of dry eye disease

FDA approves Alcon’s Tryptyr (AR-15512) for signs and symptoms of dry eye disease

View More Recent Content
Advertisement
Advertisement
x
Advertise
About Us
Editorial
Contact Us
Job Board
Terms & Conditions
Privacy
Do not sell my Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Download on Apple
© 2025 MJH Life Sciences

All rights reserved.